New Key Statistics Module, Z-Score and F-Score
NYSE:EBS Key Ratios
| Market Cap $ M | 298.69 |
| Enterprise Value $ M | 1,094.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.45 |
| Price/Sales | 0.24 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,157.00 |
| EPS (TTM) $ | -11.01 |
| Beneish M-Score | -2.27 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.36 |
| EV-to-EBITDA | -3.16 |
| PEG | -- |
| Shares Outstanding M | 52.40 |
| Net Margin (%) | -48.83 |
| Operating Margin % | -1.22 |
| Pre-tax Margin (%) | -48.25 |
| Quick Ratio | 0.55 |
| Current Ratio | 1.08 |
| ROA % (ttm) | -26.54 |
| ROE % (ttm) | -67.78 |
| ROIC % (ttm) | -0.73 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.04 |
EBS Number of Guru Trades
EBS Volume of Guru Trades
Gurus Latest Trades with NYSE:EBS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:EBS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Emergent BioSolutions Inc Insider Transactions
No Available Data
News about NYSE:EBS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers